Voices From TCT 2015: Craig Thompson On What's Next For Synergy
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's Craig Thompson discusses his firm's ongoing work to expand the indication for its newly approved Synergy drug-eluting stent with bioresorbable polymer in this "Gray Sheet" podcast.